Search

everythinglearnresearchcommunity

for

Search:↓

Platelet preparations generally show positive effects on wound healing and facial rejuvenation, but more thorough research is needed to confirm their effectiveness.

PRP treatment may increase hair density and reduce hair loss, but more research is needed.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Minoxidil boosts hair growth by triggering growth factor release from specific stem cells.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

WNT10A mutations cause varied symptoms in patients with odonto-onycho-dermal dysplasia.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Hyaluronic acid-based HA2 hydrogel helps heal skin wounds better with less scarring.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Erbium glass laser treatment may help with skin remodeling, reduce inflammation, and improve skin cell maturation.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Tissue stiffness affects hair follicle regeneration, and Twist1 is a key regulator.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.